MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1

Xiaogang Liu1, Lihong Ma1, Qinhua Rao1

  • 1Department of Gynaecology and Obstetrics, People's Hospital of Yuxi, Yuxi, Yunnan, China (mainland).

Abstract

Insights

Low levels of microRNA-1271 (miR-1271) in ovarian cancer promote tumor growth. Restoring miR-1271 may serve as a prognostic marker and therapeutic target for ovarian cancer.

Area of Science:

  • Gynecology
  • Oncology
  • Molecular Biology

Background:

  • Ovarian cancer is a leading cause of gynecological cancer deaths.
  • MicroRNA (miRNA) dysfunction is implicated in ovarian cancer pathogenesis.

Purpose of the Study:

  • To investigate the role of miR-1271 in ovarian cancer.
  • To identify miR-1271 as a potential prognostic biomarker.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure miR-1271 levels.
  • Transfection techniques to overexpress or inhibit miR-1271.
  • MTT assay for cell proliferation analysis.
  • Bioinformatics and dual luciferase reporter assay to identify targets.
  • Western blotting for protein level assessment.

Main Results:

  • Ovarian cancer tissues and cells exhibit reduced miR-1271 expression.
  • Low miR-1271 levels correlate with poor patient survival.
  • Overexpression of miR-1271 suppressed ovarian cancer cell proliferation.
  • miR-1271 directly targets the 3' untranslated region (UTR) of cyclin G1 (CCNG1).

Conclusions:

  • Reduced miR-1271 expression promotes ovarian cancer cell proliferation.
  • miR-1271 shows potential as a prognostic indicator for ovarian cancer.
  • miR-1271 exerts its tumor-suppressive function by targeting CCNG1.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K